Approval · Notice of Compliance 935 · 2000
ACETYLCYSTEINE SOLUTION: Notice of Compliance 935
Issued December 11, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 935
- Date
- December 11, 2000
- Company
- Sabex Inc.Boucherville, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Mucolytic, antidote for acetaminophen poisoning
- Canadian reference product
- MUCOMYST (Roberts Pharmaceutical Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACETYLCYSTEINE SOLUTION | 02243098 | Marketed |
Medicinal ingredients
- ACETYLCYSTEINE 200 MG per ML